References
- Pfaller MA, Diekema DJ et al. Rare and emerging opportunistic fungal pathogens: concern for resistant beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419–4431.
- Spelberg BJ, Filler SG, Edwards JE Jr. Current treat-ment strategies for disseminated candidiasis. Clin Infect Dis 2006; 42: 244–251.
- Tortorano AM, Peman J, Bernhardt H et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospi-tal-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23 (4): 317-22.
- Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ. Variation in susceptibility of bloodstream iso-lates of Candida glabrata to fluconazole according to patient age and geographic location. J Clin Microbiol 2003; 41: 2176–2179.
- Redding SW, Kirkpatrick WR, Saville S et al. Multiple patterns of resistance to fluconazole in Candida glabrata iso-lates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J Clin Microbiol 2003; 41: 619–622.
- Hajjeh RA, Sofair AN, Harrison LH et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519–1527.
- Pfaller MA, Diekema DJ, Rinaldi MG et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005; 43 (12): 5848-5859.
- National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal suscepti-bility testing of yeasts. Approved standard M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
- Tortorano AM, Prigitano A, Biraghi E, Viviani MA. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production. J Antimicrob Chemother. 2005; 56 (4): 777-9.1°
- Tortorano AM, Rigoni AL, Biraghi E, Prigitano A, Viviani MA and the FIMUA-ECMM candidaemia study group. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 of non-albicans Candida isolates from blood. J Antimicrob Chemother. 2003; 52 (4): 679-682.